Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenido archivado el 2024-06-18

Confronting the clinical relevance of biocide induced antibiotic resistance

Objetivo

Biocides have been in use for hundreds of years for antisepsis, disinfection and preservation. Despite this widespread and ever increasing use most bacterial and fungal species remain susceptible to biocides. The dramatic increase and spread of resistance to antibiotics linked to reports of co- and cross-resistance between antibiotics and biocides raised speculations on potential hazard of biocide use. The overarching question which BIOHYPO is aimed to address is: has the use of biocides contributed to the development and spread of clinically significant antibiotic resistance in human pathogens? Core of BIOHYPO are a high throughput screening approach on collections of thousands of well characterized microorganisms and an interactive web based data analysis platform. Phenotypic screening for reduced susceptibility to biocides, detection of novel resistance genes and mobile elements, and screening for their molecular epidemiology and metagenomics will be accompanied by methodological innovation for testing, risk evaluation and registration of biocides. Altogether BIOHYPO aims to provide solid data and analysis to direct future issuing of guidelines for safe environmental, medical and industrial use of biocides.

Convocatoria de propuestas

FP7-KBBE-2008-2B
Consulte otros proyectos de esta convocatoria

Coordinador

UNIVERSITA DEGLI STUDI DI SIENA
Aportación de la UE
€ 473 856,00
Dirección
VIA BANCHI DI SOTTO 55
53100 Siena
Italia

Ver en el mapa

Región
Centro (IT) Toscana Siena
Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Silvano Focardi (Prof.)
Enlaces
Coste total
Sin datos

Participantes (12)